158 related articles for article (PubMed ID: 18003659)
1. SMAD3 prevents binding of NKX2.1 and FOXA1 to the SpB promoter through its MH1 and MH2 domains.
Minoo P; Hu L; Zhu N; Borok Z; Bellusci S; Groffen J; Kardassis D; Li C
Nucleic Acids Res; 2008 Jan; 36(1):179-88. PubMed ID: 18003659
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.
Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P
J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428
[TBL] [Abstract][Full Text] [Related]
3. Physical and functional interactions between homeodomain NKX2.1 and winged helix/forkhead FOXA1 in lung epithelial cells.
Minoo P; Hu L; Xing Y; Zhu NL; Chen H; Li M; Borok Z; Li C
Mol Cell Biol; 2007 Mar; 27(6):2155-65. PubMed ID: 17220277
[TBL] [Abstract][Full Text] [Related]
4. The MH1 domain of Smad3 interacts with Pax6 and represses autoregulation of the Pax6 P1 promoter.
Grocott T; Frost V; Maillard M; Johansen T; Wheeler GN; Dawes LJ; Wormstone IM; Chantry A
Nucleic Acids Res; 2007; 35(3):890-901. PubMed ID: 17251190
[TBL] [Abstract][Full Text] [Related]
5. Myocardin enhances Smad3-mediated transforming growth factor-beta1 signaling in a CArG box-independent manner: Smad-binding element is an important cis element for SM22alpha transcription in vivo.
Qiu P; Ritchie RP; Fu Z; Cao D; Cumming J; Miano JM; Wang DZ; Li HJ; Li L
Circ Res; 2005 Nov; 97(10):983-91. PubMed ID: 16224064
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic mechanisms modulate thyroid transcription factor 1-mediated transcription of the surfactant protein B gene.
Cao Y; Vo T; Millien G; Tagne JB; Kotton D; Mason RJ; Williams MC; Ramirez MI
J Biol Chem; 2010 Jan; 285(3):2152-64. PubMed ID: 19906647
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
Yuan W; Varga J
J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
[TBL] [Abstract][Full Text] [Related]
8. Smad3 inhibits transforming growth factor-beta and activin signaling by competing with Smad4 for FAST-2 binding.
Nagarajan RP; Liu J; Chen Y
J Biol Chem; 1999 Oct; 274(44):31229-35. PubMed ID: 10531318
[TBL] [Abstract][Full Text] [Related]
9. FOXA1 reprograms the TGF-β-stimulated transcriptional program from a metastasis promoter to a tumor suppressor in nasopharyngeal carcinoma.
Li J; Wang W; Chen S; Cai J; Ban Y; Peng Q; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Yi M; Xiang B
Cancer Lett; 2019 Feb; 442():1-14. PubMed ID: 30392786
[TBL] [Abstract][Full Text] [Related]
10. Foxp2 inhibits Nkx2.1-mediated transcription of SP-C via interactions with the Nkx2.1 homeodomain.
Zhou B; Zhong Q; Minoo P; Li C; Ann DK; Frenkel B; Morrisey EE; Crandall ED; Borok Z
Am J Respir Cell Mol Biol; 2008 Jun; 38(6):750-8. PubMed ID: 18239190
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of a transcriptional cross talk between transforming growth factor-beta-regulated Smad3 and Smad4 proteins and orphan nuclear receptor hepatocyte nuclear factor-4.
Chou WC; Prokova V; Shiraishi K; Valcourt U; Moustakas A; Hadzopoulou-Cladaras M; Zannis VI; Kardassis D
Mol Biol Cell; 2003 Mar; 14(3):1279-94. PubMed ID: 12631740
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C viral proteins interact with Smad3 and differentially regulate TGF-beta/Smad3-mediated transcriptional activation.
Cheng PL; Chang MH; Chao CH; Lee YH
Oncogene; 2004 Oct; 23(47):7821-38. PubMed ID: 15334054
[TBL] [Abstract][Full Text] [Related]
13. Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1.
Alliston T; Ko TC; Cao Y; Liang YY; Feng XH; Chang C; Derynck R
J Biol Chem; 2005 Jun; 280(25):24227-37. PubMed ID: 15849193
[TBL] [Abstract][Full Text] [Related]
14. Hoxa-9 represses transforming growth factor-beta-induced osteopontin gene transcription.
Shi X; Bai S; Li L; Cao X
J Biol Chem; 2001 Jan; 276(1):850-5. PubMed ID: 11042172
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3.
Higashi K; Inagaki Y; Fujimori K; Nakao A; Kaneko H; Nakatsuka I
J Biol Chem; 2003 Oct; 278(44):43470-9. PubMed ID: 12917425
[TBL] [Abstract][Full Text] [Related]
16. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
[TBL] [Abstract][Full Text] [Related]
17. The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-beta repression of the sodium/iodide symporter gene.
Costamagna E; García B; Santisteban P
J Biol Chem; 2004 Jan; 279(5):3439-46. PubMed ID: 14623893
[TBL] [Abstract][Full Text] [Related]
18. Hydrophobic patches on SMAD2 and SMAD3 determine selective binding to cofactors.
Miyazono KI; Moriwaki S; Ito T; Kurisaki A; Asashima M; Tanokura M
Sci Signal; 2018 Mar; 11(523):. PubMed ID: 29588413
[TBL] [Abstract][Full Text] [Related]
19. Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-beta1-stimulated collagenase-3 expression in human breast cancer cells.
Selvamurugan N; Kwok S; Partridge NC
J Biol Chem; 2004 Jun; 279(26):27764-73. PubMed ID: 15084595
[TBL] [Abstract][Full Text] [Related]
20. The novel PIAS-like protein hZimp10 enhances Smad transcriptional activity.
Li X; Thyssen G; Beliakoff J; Sun Z
J Biol Chem; 2006 Aug; 281(33):23748-56. PubMed ID: 16777850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]